Heart valve replacement through a catheter for leaky mitral valve
Part of Heart & circulation clinical trials.
This trial studies a new way to replace a damaged mitral heart valve using a catheter (a thin tube), instead of open-heart surgery. It may help people who have severe leaking of the mitral valve but are considered too high-risk for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 65 years old
- Your mitral valve leak is severe (rated 3+ or higher)
- You are considered high-risk for open mitral valve surgery and not a surgical candidate
- You are expected to live more than 12 months
- You can sign informed consent (agree to join the study)
- You have not had prior mitral valve surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a new catheter-based system can replace a badly leaking mitral valve in people who have symptoms. It may help if you can’t safely get current approved valve treatments or standard surgery.
This trial studies a new transcatheter (through the heart without open surgery) mitral valve treatment for people with severe mitral valve leaking who are too high-risk for standard surgery. It may help reduce valve leakage and improve symptoms, but it’s an early “first-in-human” device study.
This trial tests whether a catheter-based procedure can safely repair a leaking mitral heart valve in people who still have symptoms despite best medical treatment. If you qualify, it may improve symptoms and heart function without open-heart surgery.
This trial is testing a new polymer artificial heart valve for people with severe mitral valve problems. It aims to see if this valve is safe and works well during surgical replacement.
This trial studies a catheter-based procedure to replace the mitral valve in people with severe (or specific moderate) mitral valve leakage that causes symptoms. It may help by reducing leaking and related symptoms when standard surgery or less invasive fixes aren’t suitable for you.
This study tests a new catheter-based system to treat severe mitral valve leaking when open-heart surgery is considered high risk. It may help improve blood flow and symptoms by repairing the valve without open surgery, using ultrasound guidance and follow-up visits to track safety and results.
Hear when a new Mitral Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.